Thrive Capital Management (Pennsylvania)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Buy |
486
+151
| +45% | +$118K | 0.12% | 132 |
|
|
2025
Q1 | $277K | Buy |
+335
| New | +$277K | 0.17% | 100 |
|
|
2024
Q4 | – | Sell |
-504
| Closed | -$447K | – | 141 |
|
|
2024
Q3 | $447K | Buy |
504
+15
| +3% | +$13.3K | 0.21% | 131 |
|
|
2024
Q2 | $443K | Buy |
489
+3
| +0.6% | +$2.72K | 0.2% | 133 |
|
|
2024
Q1 | $378K | Buy |
486
+51
| +12% | +$39.7K | 0.2% | 69 |
|
|
2023
Q4 | $254K | Buy |
435
+1
| +0.2% | +$583 | 0.14% | 116 |
|
|
2023
Q3 | $233K | Buy |
+434
| New | +$233K | 0.13% | 120 |
|